2280.SR
Almarai Company [2280.SR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2280.SR Stock Summary
In the News
2280.SR Financial details
Company Rating
Buy
Market Cap
57.1B
Income
2.05B
Revenue
19.58B
Book val./share
17.8
Cash/share
2.59
Dividend
1
Dividend %
1.62%
Employees
42K
Optionable
No
Shortable
Yes
Earnings
08 Apr 2024
P/E
29.9
Forward P/E
-
PEG
18.46
P/S
3.16
P/B
3.48
P/C
22.32
P/FCF
124.1
Quick Ratio
0.3
Current Ratio
1.46
Debt / Equity
0.7
LT Debt / Equity
0.5
-
-
EPS (TTM)
2.08
EPS next Y
-
EPS next Q
-
EPS this Y
16.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.59%
Revenue last 5Y
6.41%
Revenue Q/Q
2.56%
EPS Q/Q
-24.49%
-
-
-
-
SMA20
-1.72%
SMA50
-1.72%
SMA100
3.64%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
12%
ROC
0.1%
Gross Margin
31%
Oper. Margin
15%
Profit Margin
10%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
53.2-71.0
52W High
-18.59%
52W Low
+9.06%
RSI
52
Rel Volume
0.74
Avg Volume
995.18K
Volume
741.38K
Perf Week
1.23%
Perf Month
0.35%
Perf Quarter
7.24%
Perf Half Y
2.12%
-
-
-
-
Beta
0.348
-
-
Volatility
0.31%, 0.59%
Prev Close
0%
Price
57.8
Change
-0.34%
2280.SR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 14.53 | 15.66 | 16.15 | 19.07 | 19.88 | |
| Net income per share | 1.83 | 2.02 | 1.59 | 1.79 | 2.08 | |
| Operating cash flow per share | 4.79 | 4.29 | 5.01 | 3.9 | 4.55 | |
| Free cash flow per share | 2.36 | 2.52 | 2.78 | 1.64 | 0.87 | |
| Cash per share | 1.16 | 0.51 | 0.64 | 0.57 | 2.63 | |
| Book value per share | 14.84 | 16 | 16.42 | 16.98 | 18.08 | |
| Tangible book value per share | 14.31 | 15.31 | 15.78 | 16.13 | 16.95 | |
| Share holders equity per share | 14.84 | 16 | 16.42 | 16.98 | 18.08 | |
| Interest debt per share | 14.29 | 12.4 | 10.79 | 10.69 | 13.27 | |
| Market cap | 48.89B | 53.84B | 47.85B | 52.53B | 54.94B | |
| Enterprise value | 61.86B | 65.02B | 57.49B | 62.05B | 66.75B | |
| P/E ratio | 26.98 | 27.13 | 30.6 | 29.85 | 26.81 | |
| Price to sales ratio | 3.41 | 3.51 | 3.02 | 2.81 | 2.81 | |
| POCF ratio | 10.33 | 12.81 | 9.74 | 13.72 | 12.26 | |
| PFCF ratio | 21.01 | 21.8 | 17.54 | 32.71 | 64.11 | |
| P/B Ratio | 3.34 | 3.43 | 2.97 | 3.15 | 3.09 | |
| PTB ratio | 3.34 | 3.43 | 2.97 | 3.15 | 3.09 | |
| EV to sales | 4.31 | 4.23 | 3.63 | 3.31 | 3.41 | |
| Enterprise value over EBITDA | 12.83 | 13.65 | 13.33 | 12.76 | 12.53 | |
| EV to operating cash flow | 13.07 | 15.47 | 11.7 | 16.2 | 14.89 | |
| EV to free cash flow | 26.59 | 26.32 | 21.07 | 38.64 | 77.89 | |
| Earnings yield | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | |
| Free cash flow yield | 0.05 | 0.05 | 0.06 | 0.03 | 0.02 | |
| Debt to equity | 0.92 | 0.74 | 0.63 | 0.6 | 0.7 | |
| Debt to assets | 0.41 | 0.36 | 0.32 | 0.31 | 0.34 | |
| Net debt to EBITDA | 2.69 | 2.35 | 2.24 | 1.96 | 2.22 | |
| Current ratio | 1.28 | 1.56 | 1.07 | 1.6 | 1.4 | |
| Interest coverage | 4.25 | 5.28 | 5.55 | 5.29 | 4.56 | |
| Income quality | 2.63 | 2.17 | 3.11 | 2.15 | 2.19 | |
| Dividend Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | 0.47 | 0.43 | 0.63 | 0.56 | 0.48 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | |
| Capex to operating cash flow | -0.51 | -0.41 | -0.44 | -0.58 | -0.81 | |
| Capex to revenue | -0.17 | -0.11 | -0.14 | -0.12 | -0.19 | |
| Capex to depreciation | -1.11 | -0.82 | -1.02 | -0.93 | -1.49 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 24.75 | 26.99 | 24.26 | 26.17 | 29.09 | |
| ROIC | 0.08 | 0.09 | 0.07 | 0.08 | 0.08 | |
| Return on tangible assets | 0.06 | 0.06 | 0.05 | 0.06 | 0.06 | |
| Graham Net | -13.42 | -12.29 | -11.3 | -10.74 | -11.27 | |
| Working capital | 1.6B | 2.61B | 478.14M | 3.04B | 3.27B | |
| Tangible asset value | 14.13B | 15.02B | 15.49B | 15.84B | 16.69B | |
| Net current asset value | -10.56B | -8.82B | -8.03B | -6.96B | -6.93B | |
| Invested capital | 0.92 | 0.74 | 0.63 | 0.6 | 0.7 | |
| Average receivables | 1.82B | 1.66B | 1.56B | 1.66B | 1.9B | |
| Average payables | 1.42B | 1.3B | 1.26B | 1.3B | 1.6B | |
| Average inventory | 4.13B | 4.55B | 4.63B | 4.92B | 5.82B | |
| Days sales outstanding | 45.43 | 36.67 | 36.39 | 33.89 | 38.61 | |
| Days payables outstanding | 57.02 | 44.5 | 44.79 | 35.29 | 50.58 | |
| Days of inventory on hand | 174.46 | 178.22 | 151.26 | 149.36 | 164.9 | |
| Receivables turnover | 8.03 | 9.95 | 10.03 | 10.77 | 9.45 | |
| Payables turnover | 6.4 | 8.2 | 8.15 | 10.34 | 7.22 | |
| Inventory turnover | 2.09 | 2.05 | 2.41 | 2.44 | 2.21 | |
| ROE | 0.12 | 0.13 | 0.1 | 0.11 | 0.12 | |
| Capex per share | -2.44 | -1.77 | -2.23 | -2.26 | -3.68 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.84 | 5.16 | 4.88 | 4.87 | 4.92 | |
| Net income per share | 0.36 | 0.65 | 0.57 | 0.49 | 0.37 | |
| Operating cash flow per share | 1.08 | 0.54 | 1.53 | 0.33 | 1.74 | |
| Free cash flow per share | 0.49 | -0.22 | 0.82 | -0.59 | 0.47 | |
| Cash per share | 0.56 | 0.48 | 0.77 | 2.41 | 2.59 | |
| Book value per share | 16.67 | 17.55 | 17.11 | 17.74 | 17.8 | |
| Tangible book value per share | 15.84 | 16.41 | 15.97 | 16.61 | 16.69 | |
| Share holders equity per share | 16.67 | 17.55 | 17.11 | 17.74 | 17.8 | |
| Interest debt per share | 10.2 | 10.38 | 10.94 | 13.07 | 12.68 | |
| Market cap | 53.5B | 55.39B | 62.13B | 62.51B | 55.8B | |
| Enterprise value | 63.02B | 65B | 71.96B | 74.76B | 67.61B | |
| P/E ratio | 37.59 | 21.8 | 27.88 | 32.14 | 37.63 | |
| Price to sales ratio | 11.06 | 10.93 | 12.96 | 13.03 | 11.34 | |
| POCF ratio | 49.76 | 104.65 | 41.25 | 189.57 | 32.11 | |
| PFCF ratio | 108.4 | -251.36 | 77.11 | -107.45 | 117.89 | |
| P/B Ratio | 3.21 | 3.21 | 3.69 | 3.57 | 3.14 | |
| PTB ratio | 3.21 | 3.21 | 3.69 | 3.57 | 3.14 | |
| EV to sales | 13.02 | 12.83 | 15.02 | 15.59 | 13.74 | |
| Enterprise value over EBITDA | 44.03 | 80.1 | 55.83 | 60.3 | 49.08 | |
| EV to operating cash flow | 58.61 | 122.82 | 47.78 | 226.74 | 38.91 | |
| EV to free cash flow | 127.69 | -294.99 | 89.32 | -128.52 | 142.85 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | 0 | 0.01 | -0.01 | 0.01 | |
| Debt to equity | 0.6 | 0.58 | 0.63 | 0.73 | 0.7 | |
| Debt to assets | 0.31 | 0.31 | 0.32 | 0.36 | 0.34 | |
| Net debt to EBITDA | 6.65 | 11.85 | 7.63 | 9.89 | 8.58 | |
| Current ratio | 1.6 | 1.15 | 1.12 | 1.46 | 1.4 | |
| Interest coverage | 5.12 | 6.66 | 5.27 | 5.01 | 2.58 | |
| Income quality | 3.03 | 0.83 | 2.7 | 0.68 | 4.67 | |
| Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
| Payout ratio | 0 | 0 | 1.76 | 0 | 0 | |
| Sales general and administrative to revenue | -0.04 | 0.02 | 0.02 | 0.02 | -0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | -0.54 | -1.42 | -0.47 | -2.76 | -0.73 | |
| Capex to revenue | -0.12 | -0.15 | -0.15 | -0.19 | -0.26 | |
| Capex to depreciation | -0.77 | -1.23 | -1.23 | -1.54 | -1.9 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 11.55 | 15.98 | 14.77 | 14.03 | 12.18 | |
| ROIC | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Graham Net | -10.54 | -10.28 | -11.03 | -10.75 | -11.1 | |
| Working capital | 3.04B | 1.15B | 1.07B | 3.68B | 3.27B | |
| Tangible asset value | 15.84B | 16.12B | 15.7B | 16.38B | 16.69B | |
| Net current asset value | -6.96B | -6.58B | -7.08B | -6.7B | -6.93B | |
| Invested capital | 0.6 | 0.58 | 0.63 | 0.73 | 0.7 | |
| Average receivables | 2.17B | 2.42B | 3.03B | 2.99B | 2.55B | |
| Average payables | 2.47B | 2.68B | 4.36B | 4.31B | 2.96B | |
| Average inventory | 5.28B | 5.41B | 5.7B | 6.1B | 6.27B | |
| Days sales outstanding | 32.33 | 55.25 | 55.32 | 56.81 | 37.88 | |
| Days payables outstanding | 32.51 | 106.78 | 128.92 | 107.95 | 44.4 | |
| Days of inventory on hand | 137.62 | 142.52 | 165.89 | 169.01 | 144.76 | |
| Receivables turnover | 2.78 | 1.63 | 1.63 | 1.58 | 2.38 | |
| Payables turnover | 2.77 | 0.84 | 0.7 | 0.83 | 2.03 | |
| Inventory turnover | 0.65 | 0.63 | 0.54 | 0.53 | 0.62 | |
| ROE | 0.02 | 0.04 | 0.03 | 0.03 | 0.02 | |
| Capex per share | -0.58 | -0.76 | -0.71 | -0.92 | -1.26 |
2280.SR Frequently Asked Questions
What is Almarai Company stock symbol ?
Almarai Company is a SA stock , located in Riyadh of Riyadh province and trading under the symbol 2280.SR
What is Almarai Company stock quote today ?
Almarai Company stock price is $57.8 today.
Is Almarai Company stock public?
Yes, Almarai Company is a publicly traded company.
Company Profile
- Volume Average 995.18K
- Market Capitalization 57.1B
- Employee 42K
- CEO Mr. Abdullah Nasser Albader
- Headquarters Riyadh,Riyadh Province,SA
- IPO Date 2010-03-04
-
Website
https://www.almarai.com 
Almarai Company, together with its subsidiaries, operates as an integrated consumer food and beverage company in Saudi Arabia, Egypt, Jordan, and other Gulf Cooperation Council countries. It operates through Dairy and Juice, Bakery, Poultry, and Other Activities segments. The company offers dairy, fruit juice, and related food products under the Almarai, Joosy Life, Beyti, and Teeba brand names; bakery products under the L'usine and 7 Days brand names; and poultry products under the Alyoum and AlBashayer brand names. It also owns and operates arable farms; provides horticulture services; and manufactures infant nutrition products under the Nuralac and Evolac brand names. The company was founded in 1977 and is headquartered in Riyadh, Saudi Arabia.
